Why not cars?
That's the thinking behind car subscription services that are cropping up in Los Angeles, San Francisco, the New York metro area, Atlanta, and several other cities in the South and Midwest. For a monthly fee and a minimal commitment, you get a car with a warranty, maintenance, roadside assistance, a prescribed mileage allowance and, typically, insurance.
Several carmakers have launched subscription services: Access by BMW, Book by Cadillac, Porsche Passport, Care by Volvo, and Canvas, which offers Ford and Lincoln models. Mercedes-Benz's Collection service starts in June.
Car dealership groups and startup companies also are latching onto the idea. With the exception of Volvo, the cars are not brand new, but with a few exceptions, they are from the current or just-prior model year.
Top Insurance Stocks For 2018: Amgen Inc.(AMGN)
Advisors' Opinion:- [By ]
This week we get our first look at quarterly numbers from major drug and biotech giants such as AbbVie (ABBV) , Amgen (AMGN) , Biogen (BIIB) , Biomarin Pharmaceuticals (BMRN) and Action Alerts PLUS holding Eli Lilly (LLY) , which all provide the market a glimpse of how the first quarter was for the industry over the next few days," according to Real Money Pro columnist Bret Jensen.
- [By Cory Renauer]
There's a lot for investors to like about�Amgen Inc. (NASDAQ:AMGN) and�Biogen Inc. (NASDAQ:BIIB). Both of these biotech stocks have produced tremendous returns over the past couple of decades, and the businesses they represent still generate enormous profits.�
- [By ]
Amgen (NASDAQ: AMGN) for example, announced FDA approval of its heart-attack prevention therapy on Dec 1. Immediately after, the stock popped 15% in less than two months, moving from $177.20 to $199.
- [By Chris Lange]
Amgen Inc. (NASDAQ: AMGN) is waiting for the FDA to review its Biologics License Application (BLA) for Aimovig (erenumab) for the prevention of migraine in patients experiencing four or more migraine days per month. The FDA has set a PDUFA date for May 17.
- [By Trey Thoelcke]
Amgen Inc. (NASDAQ: AMGN) shares saw a nice bump after the U.S. Food and Drug Administration (FDA) on Thursday approved Aimovig (erenumab), Amgen’s preventive treatment of migraine in adults. It is the first FDA-approved preventive migraine treatment in a new class of drugs, which work by blocking the activity of calcitonin gene-related peptide, which is believed to play a critical role in migraine attacks.
Top Insurance Stocks For 2018: Credo Petroleum Corporation(CRED)
Advisors' Opinion:- [By Shane Hupp]
Sawtooth Solutions LLC boosted its holdings in shares of iShares Core U.S. Credit Bond ETF (NASDAQ:CRED) by 24.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 230,300 shares of the company’s stock after purchasing an additional 44,773 shares during the quarter. iShares Core U.S. Credit Bond ETF makes up 2.2% of Sawtooth Solutions LLC’s holdings, making the stock its 10th largest position. Sawtooth Solutions LLC’s holdings in iShares Core U.S. Credit Bond ETF were worth $25,096,000 as of its most recent SEC filing.
Top Insurance Stocks For 2018: icad inc.(ICAD)
Advisors' Opinion:- [By Lisa Levin]
No comments:
Post a Comment